REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

STIFEL FINANCIAL CORP's Holding History (CIK: 0000720672)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 66,325 Value ($000) $170 Avg Close — Range —
Q1 2024
Shares 67,158 Value ($000) $330 Avg Close — Range —
Q4 2023
Shares 18,947 Value ($000) $167 Avg Close — Range —
Q3 2023
Shares 14,956 Value ($000) $172 Avg Close — Range —
Q2 2023
Shares 14,256 Value ($000) $361 Avg Close — Range —
Q1 2023
Shares 14,916 Value ($000) $480 Avg Close — Range —
Q4 2022
Shares 16,952 Value ($000) $313 Avg Close — Range —
Q3 2022
Shares 21,702 Value ($000) $586 Avg Close — Range —
Q2 2022
Shares 16,761 Value ($000) $232 Avg Close — Range —
Q3 2021
Shares 15,847 Value ($000) $442 Avg Close — Range —
Q2 2021
Shares 12,180 Value ($000) $362 Avg Close — Range —
Q1 2021
Shares 12,096 Value ($000) $338 Avg Close — Range —
Q4 2020
Shares 13,877 Value ($000) $393 Avg Close — Range —
Q3 2020
Shares 10,991 Value ($000) $276 Avg Close — Range —
Q2 2020
Shares 13,722 Value ($000) $335 Avg Close — Range —
Q1 2020
Shares 13,620 Value ($000) $204 Avg Close — Range —
Q4 2019
Shares 19,461 Value ($000) $319 Avg Close — Range —
Q3 2019
Shares 23,757 Value ($000) $312 Avg Close — Range —
Q2 2019
Shares 21,804 Value ($000) $286 Avg Close — Range —
Q1 2019
Shares 27,921 Value ($000) $438 Avg Close — Range —